Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2024
Reporting Period: Event-specific (November 6, 2024)
This filing serves as a Regulation FD disclosure to announce an upcoming corporate event. It does not contain periodic financial results or operational updates beyond the scheduled presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a scheduled conference appearance and does not include financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a future event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, Chair and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference.
- Date and Time: Wednesday, November 13, 2024, at 3:30 p.m. Eastern time.
- Disclosure Status: The press release (Exhibit 99.1) is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Guggenheim Healthcare Innovation Conference fireside chat (November 13, 2024).
- Review the attached press release (Exhibit 99.1) for specific details on the presentation topic.
- Confirm that no financial data or guidance was released in this specific 8-K filing.